冠昊生物 (300238)

Guanhao Biotech Co., Ltd

ASZ

Tags

Special Purpose Equipment ManufacturingSpecialized-Sophisticated-Distinctive-Innovative EnterprisesBrain-Computer InterfaceImmunotherapyVenture Capital ConceptInnovative DrugsMedical DevicesMedical Aesthetics ConceptPharmaceuticals and HealthcareFace Mask ProtectionGene ConceptMicro and Small Cap StocksBiological Vaccines

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 26515.57
  • Circulating A-Shares(W): 26513.41
  • Earnings Per Share(RMB): 0.1000
  • Net Assets Per Share(RMB): 2.1577
  • Operating Revenue(W RMB): 29348.04
  • Total Profit(W RMB): 3211.95
  • Net Profit Attributable to Parent(W RMB): 2671.85
  • Net Profit Growth Rate(%): -4.02
  • Weighted Return on Equity(%): 4.7900
  • Operating Cash Flow Per Share(RMB): 0.1990
  • Undistributed Profit Per Share(RMB): -1.0999
  • Capital Reserve Per Share(RMB): 2.2418

2. Main Business

The main business covers:

  • Materials Business Segment
  • Pharmaceutical Business Segment
  • Cell Business Segment

3. Company Basic Information

  • Company Name: Guanhao Biotech Co., Ltd.
  • Listing Date: 2011-07-06
  • Industry: Medical & Healthcare - Medical Devices / Special Purpose Equipment Manufacturing
  • Address: No. 12 Yuyan Road, Huangpu District, Guangzhou City, Guangdong Province
  • Website: www.guanhaobio.com
  • Company Profile: On May 12, 2008, Guanhao Limited held a shareholders' meeting and resolved to transform Guanhao Limited into a joint stock company. On May 13, 2008, Guanhao Limited's shareholder Guangzhou Zhiguang and 26 natural person shareholders jointly signed the "Sponsorship Agreement for Guangdong Guanhao Biotechnology Co., Ltd. (Preparatory)", stipulating that the original 27 shareholders of Guanhao Limited would serve as the promoters of the joint stock company, with each promoter subscribing to the shares of the joint stock company according to their share of the net assets in Guanhao Limited. According to the Audit Report (No. 14193 of Yangcha 2008) issued by Lixin Yangcheng Certified Public Accountants Co., Ltd., as of April 30, 2008, the net assets of Guanhao Limited were RMB 34,522,592.28. The company converted the net assets as of the above audit reference date into 31 million shares, with the amount of actual capital contribution exceeding the registered capital recorded into capital reserve. On June 11, 2008, upon approval by the Guangdong Provincial Administration for Industry and Commerce, the company completed the industrial and commercial change registration and obtained the business license for a corporate legal person (Registration No.: 440000000024725), with a registered capital of RMB 31 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Beijing Century Tianfu Venture Investment Center (Limited Partnership) General Legal Person 3601.63 13.58
2 Beijing Tianyou Ruiyuan Pharmaceutical Technology Co., Ltd. General Legal Person 1708.48 6.44
3 Tibet Jin’gan Enterprise Management Consulting Co., Ltd. General Legal Person 1000.00 3.77
4 Guangdong Zhiguang Biotechnology Co., Ltd. General Legal Person 731.00 2.76
5 Xingbao International Trust Co., Ltd. - Huarong Huiying No. 32 Securities Investment Single Fund Trust Asset Management Plan 411.00 1.55
6 Yongying CSI All Share Medical Devices Exchange Traded Open-End Index Securities Investment Fund Fund 131.28 0.50

5. Concept Sectors

  • Venture Capital Concept
  • Biological Vaccine
  • Gene Concept
  • Immunotherapy
  • Mask Protection
  • Medical Aesthetics Concept
  • Brain-Computer Interface
  • Innovative Drugs
  • Specialized, Refined, Differential and Innovative Enterprises
  • Micro and Small Cap Stocks

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information